Disease | multiple endocrine neoplasia type 1 |
Comorbidity | C0023890|cirrhosis |
Sentences | 3 |
PubMedID- 22259000 | Selection criteria: all randomised clinical trials comparing bezafibrate at any dose or regimen in patients with primary biliary cirrhosis with placebo or no intervention, or with another drug. |
PubMedID- 24868265 | Surgery for acute abdomen in a patient with liver cirrhosis is an unavoidable risk, but its quantification is particularly significant given that modern medicine is based on analysis, objectivity and rigorous control of medical care quality. |
PubMedID- 25038208 | Showed that modulation of gut microecology and acidification of gut lumen in patients with liver cirrhosis and mhe by treatment with synbiotics resulted in increased fecal content of non–urease-producing lactobacillus species, whereas the number of urease-producing pathogenic escherichia coli and staphylococcal species decreased. |
Page: 1